Greenbrook TMS Return on Equity

Greenbrook TMS (GBNH) currently reports a ROE of 37.67%. That is above the Healthcare sector average of 21.67%. Use the charts on this page to explore Greenbrook TMS's ROE history and peer comparisons.

Greenbrook TMS's ROE of 37.67% is higher than the Healthcare sector average of 21.67%. That is roughly 73.8% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Greenbrook TMS's current 37.67% should be judged against Healthcare norms (sector average: 21.67%) and against GBNH's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 37.67%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 21.67%. From there, open related valuation or income-statement pages for Greenbrook TMS, and consider following GBNH for alerts when major investors trade the stock.

Greenbrook TMS is classified in the Healthcare sector. On ROE, it currently shows 37.67% versus a sector average near 21.67%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing GBNH with unrelated industries.